Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:isotopically modified compound
go back to main search page
Accession:CHEBI:139358 term browser browse the term
Definition:Any molecular entity in which the isotopic ratio of nuclides for at least one element deviates measurably from that occurring in nature. The term includes both isotopically substituted compounds (in which essentially all the molecules of the compound have only the indicated nuclide(s) at each designated position) and isotopically labeled compounds (a formal mixture of an isotopically unmodified compound with one or more analogous isotopically substituted compound(s).
Synonyms:related_synonym: isotopically modified compounds


show annotations for term's descendants           Sort by:
 
2-deoxy-2-((18)F)fluoro-D-glucose term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc2a1 solute carrier family 2 member 1 multiple interactions
affects uptake
ISO [MRK 003 results in decreased expression of SLC2A1 protein] which results in decreased uptake of Fluorodeoxyglucose F18
SLC2A1 mRNA affects the uptake of Fluorodeoxyglucose F18
CTD PMID:16595493, PMID:20197467 NCBI chr 5:138,154,677...138,182,897
Ensembl chr 5:138,154,673...138,182,897
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19801
    chemical entity 19800
      molecular entity 19796
        isotopically modified compound 1
          ((18)O)water 0
          ((201)Tl)thallium monochloride 0
          (11)C-modified compound + 0
          (13)C-modified compound + 0
          (13)N-modified compound + 0
          (14)C-modified compound + 0
          (15)N-modified compound + 0
          (18)F radiopharmaceutical + 1
          (223)RaCl2 0
          chlormerodrin ((197)Hg) 0
          chlormerodrin ((203)Hg) 0
          deuterated compound + 0
          sodium 2-((125)I)iodohippurate 0
          sodium 2-((131)I)iodohippurate 0
          tritiated compound + 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.